Via Pharmaceuticals
(OTC) VIAP
Via Pharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$9.60M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-1096.17 (Low)
Dividend
$0.00
Beta (Volatility)
-1096.17 (Low)
Price
$0.00
Volume
9
Open
$0.00
Price
$0.00
Volume
9
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
-1096.17 (Low)
Price
$0.00
Volume
9
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
VIAP News
VIAP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Via Pharmaceuticals
VIAP Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
33%
Return on Assets
-19%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$0.00
Shares Outstanding
20.56M
Volume
9
Short Interest
0.00%
Avg. Volume
0
Financials (TTM)
Gross Profit
$0.00
Operating Income
$6.02M
EBITDA
$5.84M
Operating Cash Flow
$6.11M
Capital Expenditure
$0.00
Free Cash Flow
$6.11M
Cash & ST Invst.
$84.00K
Total Debt
$14.00M
Via Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$0.00
N/A
Market Cap/Employee
N/A
N/A
Employees
6
N/A
Net Income
$2.47M
+41.8%
EBITDA
$876.99K
+68.5%
Quarterly Fundamentals
Net Cash
$13.92M
-78.3%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$14.00M
+40.1%
Return on Assets
-19.20%
N/A
Return on Invested Capital
32.56%
N/A
Free Cash Flow
$1.19M
+50.3%
Operating Cash Flow
$1.19M
+50.3%